CODI 16.61 Compass Diversified Holdings $CODI Hit a 52 week

New Post Public Reply Private Reply Replies (0) Message Board
Emylers
CODI 16.61 Compass Diversified Holdings $CODI Hit a 52 week low of 16.08 Closing the day 10:45 at 16.61 -0.22 -1.31% With a day low of 16.08 and a total volume of 435,396.

CODI Recent Posts: http://investorshangout.com/Compass-Diversifi...ODI-50585/

CODI Compass Diversified Holdings Recent Headline News

Is Raven Industries (RAVN) Likely to Miss Earnings in Q3? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 1 hr 10 mins ago
Raven Industries Inc. (RAVN) is set to report third-quarter fiscal 2015 results on Nov 20, before the opening bell.
MMM: 159.21 (+0.52), CODI: 16.59 (-0.24), RAVN: 25.54 (+0.16), DHR: 82.56 (+0.19)

Post Earnings Update: Compass Diversified Has Sunk 7.2% Lower in Past Week (CODI)
Comtex SmarTrend(R) - Mon Nov 17, 1:02PM CST
When Compass Diversified (NASDAQ:CODI) reported earnings 12 days ago on November 5th, 2014, analysts, on average, expected the company to report earnings of $0.36 on sales of $322.0 million. The company actually reported EPS of $0.28 on sales of $203.1 million, missing EPS estimates by $0.08 and missing revenue estimates by $118.9 million. Shares of Compass Diversified have slipped from $18.31 to $17.00, representing a loss of 7.2%, since the company reported earnings 12 days ago.
CODI: 16.59 (-0.24)

Compass Diversified Holdings Should Compound Well Over The Long Term
Munger Fan - at Seeking Alpha - Mon Nov 17, 12:45PM CST

CODI: 16.59 (-0.24), FOXF: 14.15 (+0.06), BRK.A: 218,956.76 (+416.76)

NYSE stocks posting largest volume increases
AP - Thu Nov 13, 5:06PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on New York Stock Exchange at the close of trading:
CODI: 16.59 (-0.24), CVO: 1.86 (+0.07), FCE.A: 21.80 (+0.13), RYN: 26.46 (-0.05), EVDY: 13.32 (-0.13), TRUP: 6.34 (+0.04), MATX: 33.26 (-0.07), ZTS: 43.74 (-0.49), RCAP: 12.19 (unch), TCI: 12.18 (+0.18), AME: 51.08 (+0.02), AGM: 30.02 (-0.40)

3 Buy-Rated Dividend Stocks Leading The Pack: TCAP, TLP, CODI
at The Street - Thu Nov 13, 9:30AM CST
These 3 dividend stocks are rated a Buy by TheStreet
CODI: 16.59 (-0.24), TCAP: 22.08 (-0.08), TLP: 36.46 (+0.57)

Compass Diversified Holdings prices six million trust shares offering at USD17.50
M2 - Wed Nov 12, 4:46AM CST
Compass Diversified Holdings (CODI) (NYSE:CODI), announced on Tuesday the pricing of a public offering of 6,000,000 trust shares at a price of USD17.50 per share.
CODI: 16.59 (-0.24)

NYSE stocks posting largest percentage decreases
AP - Tue Nov 11, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on New York Stock Exchange at the close of trading:
CODI: 16.59 (-0.24), ORA: 27.34 (-0.03), W: 21.49 (-0.08), CPE: 6.02 (-0.03), SFY: 6.04 (unch), RYN: 26.46 (-0.05), DMD: 5.50 (-0.18), AU: 9.77 (+0.11), SGY: 21.30 (-0.54), VSLR: 11.50 (+0.13), MTZ: 25.22 (+0.54)

Compass Diversified (CODI) Stock Falling Today After Announcing Share Offering Pricing
at The Street - Tue Nov 11, 9:19AM CST
Compass Diversified (CODI) stock is lower after the company announced the pricing of its offering of 6 million trust shares.
CODI: 16.59 (-0.24)

Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 8:17AM CST

JRJC: 6.90 (-0.06), CODI: 16.59 (-0.24), RAX: 42.93 (-0.16), QIWI: 29.05 (-0.18), MCEP: 15.45 (+0.05), PHMD: 2.33 (+0.04), SFM: 31.22 (+0.31), VSLR: 11.50 (+0.13), VOD: 35.49 (-0.47), LITB: 7.50 (-0.27), PT: 1.76 (+0.04), THLD: 3.00 (+0.08), ZNGA: 2.69 (-0.06)

Compass Diversified -7.2% as secondary prices
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 7:38AM CST

CODI: 16.59 (-0.24)

Compass Diversified Holdings Announces Pricing of 6.0 Million Share Offering
PR Newswire - Tue Nov 11, 7:25AM CST
Compass Diversified Holdings (NYSE: CODI), announced today that it has priced a public offering of 6,000,000 trust shares at a price of $17.50 per share. CODI expects to receive approximately $105.0 million of gross proceeds from the offering. The underwriters will have a 30-day option to purchase up to an additional 900,000 trust shares from CODI. CODI will use the net proceeds from the offering to repay a portion of the outstanding balance of its revolving credit facility. The closing is expected to occur on or about November 14, 2014, subject to customary closing conditions.
CODI: 16.59 (-0.24), FOXF: 14.15 (+0.06)

Compass Diversified Holdings commences public offering of six million trust shares
M2 - Tue Nov 11, 6:02AM CST
Compass Diversified Holdings (NYSE:CODI) announced on Monday that it has commenced a public offering of 6,000,000 trust shares.
CODI: 16.59 (-0.24)

GE Capital Extends Financing to Kohlberg & Co. - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 5:50PM CST
GE Antares, a unit of General Electric Company's (GE) GE Capital, recently served as an administrative agent on a $160 million senior credit facility to Kohlberg & Company for the acquisition of PPC Industries.
CODI: 16.59 (-0.24), GE: 26.86 (+0.25), FSS: 15.48 (-0.06), CLC: 66.32 (+0.35)

United Technologies' Research Arm Wins R&D 100 Awards - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 5:15PM CST
United Technologies' (UTX) Research Arm was awarded the prestigious R&D 100 Award by R&D Magazine, recognizing and honouring two of its cutting-edge eco-friendly technologies.
CODI: 16.59 (-0.24), FSS: 15.48 (-0.06), UTX: 108.43 (+1.06), CLC: 66.32 (+0.35)

Compass Diversified announces secondary offering
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 3:20PM CST

CODI: 16.59 (-0.24)

Compass Diversified Holdings Announces Share Offering
PR Newswire - Mon Nov 10, 3:06PM CST
Compass Diversified Holdings (NYSE: CODI), announced today it has commenced a public offering of 6,000,000 trust shares, with a 30-day option for the underwriters to purchase up to an additional 900,000 trust shares. Net proceeds from the offering will be used to repay a portion of the outstanding balance of CODI's revolving credit facility.
CODI: 16.59 (-0.24), FOXF: 14.15 (+0.06)

Compass Diversified Holdings' (CODI) CEO Alan Offenberg on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Sat Nov 08, 1:05PM CST

CODI: 16.59 (-0.24)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Advocacy for Hiring Disabled Kidney Patients Gains Steam

Updated Category News Views 94

Making Jobs Accessible for Kidney Patients Well, things are stirring up on Capitol Hill, and it's high time, if you ask me. The American Association of Kidney Patients (AAKP) is rallying hard for a bipartisan bill that could change the landscape for folks grappling with kidney diseases and disabilities. You’ve got Reps Pete Sessions and Steny Hoyer pushing this American...

Continue Reading
First Citizens Surprises with Q3 Gains and Buyback Plan

Updated Category News Views 5

Unexpected Third Quarter Tailwinds for First Citizens There are days in this trading gig when a bank I'll barely sneeze at hits out of the park. First Citizens BancShares (NASDAQ:FCNCA) pulled off such a feat, wringing out a third-quarter 2026 performance that beat their own benchmarks. They threw $600 million back to shareholders in repurchased stocks while repaying an...

Continue Reading
Gentex Shares Tumble Amid Legal Investigation Concerns

Updated Category News Views 10

Gentex's Financial Outlook Takes a Hit Well, here we are again, catching another corporate hiccup. Gentex Corporation, or as ticker hounds know it, NASDAQ:GNTX, just pulled the rug out from its investors by chopping the top off its 2026 revenue guidance. Dropping to a floor it once considered a ceiling, $2.65 billion is now the most optimistic number they're pitching. No...

Continue Reading
A Game-Changer for Pediatric Diabetes: Novo's Awiqli®

Updated Category News Views 14

Breaking Through the Diabetes Treatment Wall From where I'm sitting, breakthrough approvals like Novo's Awiqli® hit the healthcare landscape with all the subtlety of a freight train. The FDA's green light for Awiqli® as the first once-weekly insulin for kids aged 10 and over with type 2 diabetes is a monumental shift in the treatment paradigm. We're talking about...

Continue Reading
Shanghai and Hamburg Celebrate 40 Years of Collaboration

Updated Category News Views 6

Strengthening the Bond: A Four-Decade Journey With fireworks of diplomacy and cooperation lighting up, Shanghai and Hamburg marked the 40th anniversary of their friendship with an ambition to deepen and broaden ties. These cities, separated by continents but united by their maritime spirit, decided to toast not just the past but also the future. This isn't just some fancy...

Continue Reading
Unicoin’s 'RISE IN PINK' Blends Crypto and Charity

Updated Category News Views 24

The New Face of Charitable Giving: Crypto and Cause Turning the spotlight on how blockchain and altruism can mesh, Unicoin's latest campaign isn’t just your average philanthropic endeavor. With 'RISE IN PINK', they're out to change the game, blending digital assets with a deep human cause—breast cancer awareness and support. Technology Meets Human Cause Imagine...

Continue Reading
York Space Systems Class Action: Deadline Approaches

Updated Category News Views 66

Rapid Deadline: October 30 Looms for York Space Systems You blink, and you might miss the deadline. We’re just a step away from deadline day in the York Space Systems’ class action lawsuit. If you've got skin in this game, time's not on your side. Shareholders, particularly those who hopped on the York Space train via their IPO back in January 2026, are staring down...

Continue Reading
Astra Security Tackles PHP2Shell Vulnerabilities Head-On

Updated Category News Views 26

Unlocking the PHP Puzzle Hot off the press, Astra Security's stepping up to the plate with some freebie tools designed to sniff out and stamp out those pesky PHP2Shell vulnerabilities—CVE-2026-109618 and CVE-2026-109619. If you're not familiar, these suckers rate a whopping 9.2 on the CVSS v4.0 scale, and that means they got the potential to let remote code execution...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 111

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
Lowcountry Kids to Get Free Helmets at Safety Events

Updated Category News Views 5

Helmets for Kids Initiative Gets Rolling Now, here's a story that's more about community care than cash flow, but hey, sometimes even a grizzled trader like me can nod in appreciation. Christmas Injury Lawyers are putting their money where their mouth is, with the Helmets for Kids initiative staged at two key events in the Lowcountry area. Yep, that's right—the legal...

Continue Reading

Top 5 Most Recently Viewed Articles

CoinW Showcases Its Innovations at Taipei Blockchain Week 2024

Updated Category News Views 261

CoinW's Impactful Presence at Taipei Blockchain Week 2024 At the forefront of innovation and security, CoinW, a globally recognized cryptocurrency exchange, recently showcased its vision for the future during Taipei Blockchain Week 2024 as a Gold Sponsor. The event, celebrated for fostering discussions on blockchain advancements, featured the launch of PropW, CoinW's...

Continue Reading
Bank of Åland Plc Seeks Trading Admission of New Covered Bonds

Updated Category News Views 170

Application for Trading Admission of Covered Bonds Bank of Åland Plc, also recognized as Ålandsbanken Abp, is taking an important step by applying for the admission of a new security to trading on Nasdaq Helsinki. This involves their recent issuance of covered bonds, which are highly regarded in the financial market. Details of the Covered Bonds Issue The primary...

Continue Reading
Simpson Manufacturing's Q3 Earnings Report Shows Challenges Ahead

Updated Category News Views 54

Simpson Manufacturing's Third Quarter Performance Simpson Manufacturing Co., Inc. (NYSE: SSD) recently announced its third-quarter earnings, and the results did not meet the expectations of analysts. This disappointing performance resulted in a 5% decline in shares during after-hours trading. The company's focus on producing wood construction products highlights the...

Continue Reading
Alvotech Faces Challenges in Biologics License Approval Process

Updated Category News Views 349

Overview of Biologics License Application Status Alvotech, a prominent biotech firm specializing in biosimilars, has recently updated the market regarding its application status for AVT05, a potential competitor to Simponi (golimumab). The company has received a complete response letter (CRL) from the U.S. Food and Drug Administration (FDA) highlighting certain...

Continue Reading
Replimune Group Faces Class Action Lawsuit Amid FDA Setback

Updated Category News Views 127

Replimune Group Faces Class Action Lawsuit Amid FDA Setback Pomerantz LLP has brought attention to a class action lawsuit involving Replimune Group, Inc. (NASDAQ: REPL). This legal action is relevant for investors who have experienced losses on their investments in the company. It's crucial for affected investors to be proactive and consider their options as they navigate...

Continue Reading